Caldwell Investment Management Ltd. Announces Soft Capping on Caldwell Canadian Value Momentum Fund
TORONTO, Oct. 26, 2021 (GLOBE NEWSWIRE) -- Caldwell Investment Management Ltd. ("Caldwell") today announced the Caldwell Canadian Value Momentum Fund (the "Fund") will be soft capped as of November 19, 2021 (the "Effective Date") due to capacity constraints.
The Fund will be closed to purchases by new investors, except as permitted by Caldwell, other than the following types of investors:
Those who purchase through a discretionary account and whose advisor has signed an acknowledgement of portfolio management registration with Caldwell.
Those who purchase through dealer model portfolio programs where the dealer has trading or discretionary authority over the portfolio and the Fund was part of the portfolio as of the Effective Date.
Investors who held units of the Fund on the Effective Date and continue to hold those units, can continue to make additional investments in the Fund. "Caldwell Canadian Value Momentum Fund's differentiated investment strategy has attracted significant assets during the past year," said Brendan Caldwell, CEO, Caldwell Investment Management Ltd. "In an effort to preserve the integrity of the fund's investment process, we are moving to close the fund to new investors. We believe this is in the best interest of investors at this time." For advisors and investors who may be interested in considering other Caldwell funds managed by portfolio manager Jennifer Radman, the Caldwell U.S. Dividend Advantage Fund remains open and available for purchases.
About Caldwell Investment Management Ltd.
Caldwell Investment Management Ltd. is a Toronto-based portfolio manager and investment fund manager that offers mutual fund and pooled fund products to Canadian investors.
Commissions, trailing commissions, management fees, performance fees and expenses all may be associated with mutual fund investments. Please read the prospectus before investing. Mutual funds are not guaranteed, their values change frequently, and past performance may not be repeated.
For additional information, please contact: Richard Faiella, Senior Vice President, at 1-800-256-2441
Genenta Science , a clinical-stage immuno-oncology company developing a cell-based platform harnessing the power of hematopoietic stem cells to provide durable and safe treatments for solid tumors, announces that it held its Ordinary and...
Li-Cycle Holdings Corp. ("Li-Cycle" or the "Company"), a leading global lithium-ion battery resource recovery company, today announced plans to release its financial results and provide a business update for its first quarter ended March 31, 2024...
Q4 Fiscal Year 2024 Highlights
Net income attributable to our common shareholder and net income from continuing operations of $166 million, up 6% YoY; Net income excluding special items was $179 million, up 2% YoYAdjusted EBITDA of $514 million, up...
Legal-Bay LLC, The Lawsuit Pre Settlement Funding Company, announced today their newfound focus on product liability claims for plaintiffs and lawyers involved in ongoing mass tort litigations. Due to increasing product liability lawsuit loan...
Shipium, the leading shipping platform for enterprise shippers and logistics service providers, today announced a partnership with Blue Yonder, a leader in digital supply chain transformations. Through the partnership, Shipium and Blue Yonder will...
GlycoMimetics, Inc. , a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and inflammatory diseases, today announced topline results from its Phase 3 global pivotal study of uproleselan in...